Correction: Interleukin−6 in complications of prematurity: from biomarker to targeted therapy

Shuzhe Xiao, Qi Zheng, Lingling Wang, Zhiqiu Wang, Guangliang Bi, Jie Yang

Open source

DOI
10.3389/fped.2026.1965753
Published
2026-09-10
Container
Frontiers in Pediatrics
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fped.2026.1965753,
  title = {Correction: Interleukin−6 in complications of prematurity: from biomarker to targeted therapy},
  author = {Shuzhe Xiao and Qi Zheng and Lingling Wang and Zhiqiu Wang and Guangliang Bi and Jie Yang},
  year = {2026},
  journal = {Frontiers in Pediatrics},
  doi = {10.3389/fped.2026.1965753},
  url = {https://doi.org/10.3389/fped.2026.1965753}
}

RIS

TY  - JOUR
TI  - Correction: Interleukin−6 in complications of prematurity: from biomarker to targeted therapy
AU  - Shuzhe Xiao
AU  - Qi Zheng
AU  - Lingling Wang
AU  - Zhiqiu Wang
AU  - Guangliang Bi
AU  - Jie Yang
PY  - 2026
JO  - Frontiers in Pediatrics
DO  - 10.3389/fped.2026.1965753
UR  - https://doi.org/10.3389/fped.2026.1965753
ER  - 

APA

Xiao, S., Zheng, Q., Wang, L., Wang, Z., Bi, G., & Yang, J. (2026). Correction: Interleukin−6 in complications of prematurity: from biomarker to targeted therapy. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2026.1965753

Source records